MIHON, M. I.; PAMFIL, C.; BEYER, R.; TOMOAIA, R.; GHERASIM, A. R.; DEAC, A.; ZDRENGHEA, M. T.; POLTORAC, V.-I.; FODOR, D. M.; MARIȘ, A.; DAMIAN, L. O.; REDNIC, S. Pembrolizumab-induced fulminant triple M syndrome presenting with severe bradycardia. Medicine and Pharmacy Reports, [S. l.], 2025. DOI: 10.15386/mpr-2834. Disponível em: https://medpharmareports.com/index.php/mpr/article/view/2834. Acesso em: 5 oct. 2025.